Taysha Gene Therapies, Inc. Fiscal Q2 2026 Earnings | StockRay
StockRay
T
Taysha Gene Therapies, Inc.
Q2 2026 earnings expected
Quarter
Apr – Jun
Expected
August 11, 2026
(ET)
Revenue Growth Trajectory
+171%
YoY
Last 7 quarters
$5M
3/24
6/24
9/24
12/24
3/25
6/25
12/25
Back to stock page
